Cargando…

Pristimerin enhances the effect of cisplatin by inhibiting the miR-23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells

Lung cancer is a common type of cancer with a high mortality rate in China. Cisplatin (Cis) is one of the most effective broad-spectrum chemotherapeutic drugs for the treatment of advanced lung cancer. However, Cis resistance remains an obstacle in the treatment of advanced lung cancer. Pristimerin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yingbing, Wang, Jiquan, Hui, Beina, Sun, Wenze, Li, Bin, Shi, Fan, Che, Shaomin, Chai, Linyan, Song, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365073/ https://www.ncbi.nlm.nih.gov/pubmed/30664149 http://dx.doi.org/10.3892/ijmm.2019.4057

Ejemplares similares

Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy
por: Sun, Wenze, et al.
Publicado: (2015)

Alantolactone enhances gemcitabine sensitivity of lung cancer cells through the reactive oxygen species-mediated endoplasmic reticulum stress and Akt/GSK3β pathway
por: Wang, Jiquan, et al.
Publicado: (2019)

Antifungal Activity of Maytenin and Pristimerin
por: Gullo, Fernanda P., et al.
Publicado: (2012)

Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis
por: Cheng, Shihuan, et al.
Publicado: (2020)

Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine
por: Hong, Yuan, et al.
Publicado: (2020)

Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss
por: Qi, Dahu, et al.
Publicado: (2021)

Pristimerin Suppresses Trophoblast Cell Epithelial–Mesenchymal Transition via miR-542-5p/EGFR Axis
por: Shu, Chang, et al.
Publicado: (2020)

miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM
por: Guo, Yuyan, et al.
Publicado: (2017)

A Hopeful Natural Product, Pristimerin, Induces Apoptosis, Cell Cycle Arrest, and Autophagy in Esophageal Cancer Cells
por: Huang, Peng, et al.
Publicado: (2019)

Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy: Comparison of Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiation Therapy
por: Hui, Beina, et al.
Publicado: (2014)

Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo
por: Mori, Yuki, et al.
Publicado: (2017)

Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
por: Li, Jia-jun, et al.
Publicado: (2019)

Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
por: Chen, Run-Ze, et al.
Publicado: (2021)

Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation
por: Lee, Younju, et al.
Publicado: (2018)

Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis
por: El-Agamy, Dina S., et al.
Publicado: (2018)

Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo
por: Zhao, Qun, et al.
Publicado: (2019)

Silencing UHRF1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Inhibiting the PI3K/Akt/mTOR Signaling Pathway
por: Hui, Beina, et al.
Publicado: (2021)

Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation
por: Mu, Xianmin, et al.
Publicado: (2012)

Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p
por: Li, Zaiyu, et al.
Publicado: (2019)

Pristimerin‐induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway
por: Yan, Fengxia, et al.
Publicado: (2020)

Pristimerin inhibits neuronal inflammation and protects cognitive function in mice with sepsis-induced brain injuries by regulating PI3K/Akt signalling
por: Xue, Weimin, et al.
Publicado: (2021)

Expression and prognostic relevance of MET and phospho-BAD in non-small cell lung cancer
por: Sun, Wenze, et al.
Publicado: (2013)

Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer
por: Sun, Wenze, et al.
Publicado: (2013)

Pristimerin induces apoptosis and inhibits proliferation, migration in H1299 Lung Cancer Cells
por: Li, Jiajun, et al.
Publicado: (2020)

Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway
por: WANG, TIAN, et al.
Publicado: (2014)

Dehydrocostuslactone Suppresses Angiogenesis In Vitro and In Vivo through Inhibition of Akt/GSK-3β and mTOR Signaling Pathways
por: Wang, Chih-Ya, et al.
Publicado: (2012)

KIF2C accelerates the development of non-small cell lung cancer and is suppressed by miR-186-3p via the AKT-GSK3β-β-catenin pathway
por: Guo, Junmei, et al.
Publicado: (2023)

Ubiquitin-proteasomal degradation of antiapoptotic survivin facilitates induction of apoptosis in prostate cancer cells by pristimerin
por: LIU, YONG BO, et al.
Publicado: (2014)

Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells
por: DEEB, DORRAH, et al.
Publicado: (2015)

Lupeol and pristimerin do not inhibit activation of the human sperm CatSper Ca(2+)-channel
por: Rehfeld, Anders, et al.
Publicado: (2022)

GSK343 induces autophagy and downregulates the AKT/mTOR signaling pathway in pancreatic cancer cells
por: Xu, Hao, et al.
Publicado: (2019)

CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis
por: Mohapatra, Pallavi, et al.
Publicado: (2021)

Pristimerin Causes G1 Arrest, Induces Apoptosis, and Enhances the Chemosensitivity to Gemcitabine in Pancreatic Cancer Cells
por: Wang, Yongwei, et al.
Publicado: (2012)

Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro
por: Yan, Yan-Yan, et al.
Publicado: (2017)

Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo
por: Sun, Peng, et al.
Publicado: (2020)

Pristimerin, a triterpene that inhibits monoacylglycerol lipase activity, prevents the development of paclitaxel-induced allodynia in mice
por: Al-Romaiyan, Altaf, et al.
Publicado: (2022)

Accurate delivery of pristimerin and paclitaxel by folic acid-linked nano-micelles for enhancing chemosensitivity in cancer therapy
por: Chen, Chao, et al.
Publicado: (2022)

AKT/GSK3 signaling pathway and schizophrenia
por: Emamian, Effat S.
Publicado: (2012)

AKT/GSK3β Signaling in Glioblastoma
por: Majewska, Ewelina, et al.
Publicado: (2016)

3,3′-Diindolylmethane Augments 5-Fluorouracil-InducedGrowth Suppression in Gastric Cancer Cells through Suppression of the Akt/GSK-3β and WNT/Beta-Catenin
por: Li, Cong Shan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tecja4ra76mmob0p815ofv8bhs